Jean‐François Patoiseau

Immunological Quantitation and Localization of ACAT-1 and ACAT-2 in Human Liver and Small Intestine

Catherine C.Y. Chang, Naomi Sakashita, Kim Ørnvold et al. · Journal of Biological Chemistry · 2000 · 231 citations · Full text

Laboratory Immunology, Immunology, Gastroenterology +20

F 11440, a Potent, Selective, High Efficacy 5-HT1AReceptor Agonist with Marked Anxiolytic and Antidepressant Potential

Wouter Koek, Jean‐François Patoiseau, M.B. Assié et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 63 citations

Human Adipocyte Fatty Acid-Binding Protein (aP2) Gene Promoter-Driven Reporter Assay Discriminates Nonlipogenic Peroxisome Proliferator-Activated Receptor γ Ligands

Yves Rival, Aline Stennevin, L. Puech et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 53 citations

Pharmacological profile of F 12511, (S)-2′,3′,5′-trimethyl-4′-hydroxy-α-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitor

Didier Junquéro, Philippe Oms, Elisabeth Carilla-Durand et al. · Biochemical Pharmacology · 2001 · 31 citations

Molecular Pharmacology, Medicinal Chemistry, Pharmaceutical Science +12

F 12511, a novel ACAT inhibitor, and atorvastatin regulate endogenous hypercholesterolemia in a synergistic manner in New Zealand rabbits fed a casein-enriched diet

Didier Junquéro, F. Bruniquel, Xuân Hồng Nguyễn et al. · Atherosclerosis · 2001 · 29 citations

Nutrition, Metabolic Syndrome, Cardiovascular Disease +12